White Label Liquid, Inc. (WLAB)

White Label Liquid, Inc. (WLAB) Materials & Commodity Exposure

White Label Liquid, Inc. specializes in custom manufacturing services for hemp-derived CBD products, including oils, vapes, and edibles, serving a global client base of brands, retailers, and distributors. The Daytona Beach-based company offers comprehensive branding, design, and packaging solutions, leveraging a daily production capacity of approximately 50,000 units to meet diverse market demands in the specialty chemicals sector.

What Is the Investment Thesis for WLAB?

White Label Liquid, Inc. (WLAB) operates within the expanding market for hemp-derived CBD products, positioning itself as a crucial white-label manufacturing partner. The company's value proposition is centered on its comprehensive, customizable production capabilities, which include product formulation, branding, design, and packaging for a diverse range of CBD oils, edibles, and topicals. With a daily production capacity of approximately 50,000 units, WLAB is equipped to serve both emerging and established brands globally, offering a scalable solution that reduces clients' capital expenditure and time-to-market. Growth catalysts for WLAB include the ongoing global legalization and increasing consumer acceptance of CBD products, driving demand for specialized manufacturing services. The company's ability to offer a broad product portfolio and tailored solutions positions it to capture market share from new entrants and existing brands seeking efficient supply chain partners. However, investors must consider risks associated with its OTC market listing, including potential liquidity constraints and limited disclosure, alongside the evolving regulatory landscape for CBD products and intense competition within the specialty chemicals and hemp-derived goods sector.

Based on FMP financials and quantitative analysis

WLAB Key Highlights

• Market Capitalization: $0.00B, indicating a micro-cap or non-publicly valued entity.
• Daily Production Capacity: Approximately 50,000 units, demonstrating significant manufacturing scale.
• Employee Count: 8 employees, suggesting a lean operational structure.
• Dividend Yield: None, as the company does not currently pay dividends.
• Global Client Base: Serves a diverse range of clients worldwide, including major brands and distributors.

Who Are WLAB's Competitors?

WLAB is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are WLAB's Key Strengths?

• High daily production capacity (50,000 units).
• Comprehensive service offering (blending, branding, design, packaging).
• Diverse product portfolio (oils, vapes, edibles, topicals).
• Global client base across various retail channels.

What Are WLAB's Weaknesses?

• Small employee base (8 employees) potentially indicating limited scalability or reliance on automation.
• Unknown disclosure status on OTC market, limiting transparency for investors.
• Market Cap of 10K suggests very low or no public market valuation.
• Dependence on the evolving regulatory landscape of hemp-derived CBD products.

What Could Drive WLAB Stock Higher?

• **Upcoming:** Potential for increased demand from new client acquisitions as the global CBD market continues to expand and regulations become clearer in new regions.
• **Ongoing:** Expansion of product offerings to include novel cannabinoids or functional ingredients, attracting a broader range of clients seeking specialized formulations.
• **Ongoing:** Strategic partnerships with larger retail chains or distributors could significantly increase order volumes and market reach.
• **Upcoming:** Any future public disclosure of financial results or operational updates could provide greater transparency and investor confidence.

What Are the Key Risks for WLAB?

• **Ongoing:** Regulatory uncertainty and potential changes in laws pertaining to hemp-derived CBD products, which could impact manufacturing or sales.
• **Ongoing:** Intense competition within the white-label CBD manufacturing sector, potentially leading to pricing pressures or loss of market share.
• **Potential:** Low liquidity and limited transparency due to its "OTC Other" listing and "Unknown" disclosure status, posing challenges for investors.
• **Ongoing:** Dependence on the availability and quality of raw materials, specifically hemp-derived CBD oil, which could be subject to supply chain disruptions.
• **Potential:** The small employee base (8 employees) could present scalability challenges or operational vulnerabilities if key personnel depart.

What Are the Growth Opportunities for WLAB?

• **Expanding Product Diversification into Novel Cannabinoids:** The market for hemp-derived products is evolving beyond CBD to include minor cannabinoids like CBG, CBN, and Delta-8/Delta-9 THC (where legal). WLAB's expertise in custom blending and manufacturing positions it to develop and produce products featuring these novel compounds. This expansion could tap into new consumer segments seeking different therapeutic effects or experiences, significantly broadening WLAB's addressable market. The ability to quickly adapt formulations and production lines for these emerging ingredients would be a key competitive advantage, potentially attracting clients seeking to innovate their product lines and capture early market share in these specialized niches, thereby driving increased order volumes and revenue streams.
• **Geographic Market Expansion and International Reach:** While WLAB serves clients worldwide, there remains significant untapped potential in specific international markets where CBD regulations are becoming more favorable. By strategically targeting countries or regions with newly established or clarified legal frameworks for hemp-derived products, WLAB can expand its client base and sales channels. This could involve establishing new distribution partnerships, attending international trade shows, or tailoring product formulations to meet specific regional regulatory requirements and consumer preferences. Such expansion would diversify revenue streams and reduce reliance on any single market, capitalizing on the global trend towards CBD acceptance and market liberalization.
• **Increased Demand for White-Label Services in a Maturing Market:** As the CBD market matures, many brands, especially smaller ones or those new to the space, prefer to outsource manufacturing to specialized partners like WLAB. This allows them to focus on marketing and distribution without the heavy capital investment in production facilities, regulatory compliance, and R&D. WLAB's comprehensive service, from concept to packaging, makes it an attractive partner. This trend is expected to intensify as competition grows, pushing brands to seek cost-effective and efficient manufacturing solutions, thereby increasing the demand for WLAB's core white-label offerings and potentially leading to larger, more consistent contracts.
• **Scaling Production Capacity and Operational Efficiency:** With a stated capacity of 50,000 units per day, WLAB has a strong foundation. However, as demand from existing and new clients grows, there will be opportunities to further optimize and potentially expand this capacity. Investing in advanced automation technologies, streamlining supply chain logistics, and enhancing quality control processes can increase throughput and reduce per-unit costs. This scaling would enable WLAB to handle larger volume orders, attract enterprise-level clients, and improve profit margins. Enhanced efficiency would also bolster the company's reputation for reliability and rapid fulfillment, crucial factors for securing long-term contracts in a competitive manufacturing landscape.
• **Strategic Partnerships with Large Retail Chains and Pharmaceutical Companies:** Forming strategic alliances with major retail chains, pharmacies, or even pharmaceutical companies looking to enter the wellness or over-the-counter CBD space presents a substantial growth opportunity. These partnerships could involve developing exclusive product lines or acting as the primary manufacturer for a large-scale private label brand. Such collaborations would provide WLAB with significant, stable revenue streams and immediate access to broad distribution networks, far exceeding what individual smaller brands could offer. The company's established production capabilities and regulatory understanding would be highly attractive to larger entities seeking a reliable manufacturing partner.

What Opportunities Does WLAB Have?

• Growing global demand for CBD and other hemp-derived products.
• Expansion into new cannabinoid product categories.
• Increased demand for white-label manufacturing services as market matures.
• Potential for strategic partnerships with larger brands or distributors.

What Threats Does WLAB Face?

• Intense competition from other contract manufacturers and larger chemical companies.
• Evolving and potentially restrictive regulatory changes in the CBD market.
• Supply chain disruptions for raw materials (hemp-derived CBD oil).
• Reputational risks associated with product quality or safety in a sensitive industry.

What Are WLAB's Competitive Advantages?

• **Integrated Service Offering:** Provides end-to-end solutions from product development to customized packaging, reducing client overhead.
• **High Production Capacity:** Ability to produce approximately 50,000 units per day allows for scalability and meeting large order demands.
• **Product Diversification:** Manufactures a broad range of CBD products, catering to various market segments and client needs.
• **Global Reach & Client Diversity:** Serves a worldwide client base, mitigating reliance on any single market or customer type.
• **Customization Expertise:** Specialization in custom blending and unique packaging solutions offers a tailored approach for brands.

What Does WLAB Do?

White Label Liquid, Inc. (WLAB), headquartered in Daytona Beach, Florida, operates as a specialized manufacturer within the Basic Materials sector, specifically in Specialty Chemicals. The company's core business revolves around providing comprehensive manufacturing services for custom-blended products primarily containing hemp-derived CBD oil. WLAB serves a diverse global clientele, encompassing major and smaller brands, chain stores, vape shops, distributors, and dealers across various international markets. Its service offering extends beyond mere production to include creative branding, design, and customized packaging solutions, ensuring that client products are engineered to meet specific market goals and aesthetic requirements. This end-to-end service model allows clients to leverage WLAB's expertise and infrastructure without the need for significant capital investment in their own manufacturing facilities, thereby reducing time-to-market and operational complexities. The company's extensive product portfolio includes a wide array of CBD-infused items such as CBD oil, terpenes oil, vape liquid, CBD gummies, infused herbs, and pre-filled vape pens. Beyond ingestibles and inhalables, WLAB also manufactures topical applications like lotions and lip balms, demonstrating a broad capability to cater to different segments of the burgeoning CBD market. This product diversity is a key differentiator, enabling clients to offer a comprehensive range under their own brand. A significant operational asset for White Label Liquid, Inc. is its robust production capacity, capable of producing approximately 50,000 units per day. This capacity is highly adaptable, allowing for various packaging sizes and shapes, complemented by custom labels and bespoke presentation packaging, which are crucial for white-label clients seeking distinct brand identities without the overhead of in-house manufacturing. This integrated approach, from product conceptualization and formulation to final packaging and delivery, positions WLAB as a comprehensive partner for businesses looking to enter or expand within the hemp-derived product space, offering scalability and customization critical for success in a competitive market.

What Products and Services Does WLAB Offer?

• Manufacture custom-blended products containing hemp-derived CBD oil.
• Create, brand, design, and customize packaging for client products.
• Produce a wide range of CBD products including oils, terpenes oil, vape liquid, gummies, and infused herbs.
• Manufacture pre-filled vape pens, lotions, and lip balms.
• Provide manufacturing services to major and small brands, chain stores, vape shops, distributors, and dealers globally.
• Operate with a production capacity of approximately 50,000 units per day.
• Engineer products to meet specific client goals and market requirements.
• Offer solutions for various packaging sizes and shapes with custom labels.

How Does WLAB Make Money?

• **Contract Manufacturing:** Generates revenue by providing specialized production services for hemp-derived CBD products to other businesses.
• **White-Label Services:** Offers comprehensive solutions including product formulation, branding, design, and packaging under clients' brand names.
• **Volume-Based Production:** Revenue is tied to the volume of units produced and the complexity of customization requested by clients.
• **Global Client Base:** Serves a diverse range of clients worldwide, from small brands to large distributors, diversifying revenue streams.

What Industry Does WLAB Operate In?

White Label Liquid, Inc. operates within the dynamic and rapidly evolving specialty chemicals industry, specifically targeting the hemp-derived CBD product market. This segment is characterized by significant growth driven by increasing consumer awareness of CBD's potential benefits and expanding legalization across various jurisdictions. The global CBD market size was estimated at over $12 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) exceeding 20% through 2030, indicating substantial demand for manufacturing and supply chain services. WLAB's positioning as a white-label manufacturer allows it to capitalize on this growth without directly incurring the extensive marketing and brand-building costs associated with consumer-facing brands. The competitive landscape includes other contract manufacturers and larger chemical companies with specialty divisions. WLAB differentiates itself through its comprehensive service offering—from custom blending and product development to branding and packaging—and its substantial daily production capacity, enabling it to serve a diverse global clientele from small businesses to major chain stores.

Who Are WLAB's Key Customers?

• Major and small consumer brands seeking to launch or expand their CBD product lines.
• Chain stores and retail outlets looking for private-label CBD products.
• Vape shops and specialized retailers requiring custom vape liquids and pens.
• Distributors and dealers who supply a network of smaller retailers.
• International businesses aiming to enter the hemp-derived product market.

Company Profile

White Label Liquid, Inc. operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Daytona Beach, US. The company is led by CEO Yaron Elkayam. WLAB has traded publicly since 2010.

How White Label Liquid, Inc. Is Valued

White Label Liquid, Inc. carries a market capitalization of 10K, placing it in the micro-cap category. Relative to its peer group, WLAB's quantitative score of 50/100 is below the peer average of 64/100.

ROE 2%Key Financial Metrics

Return on equity for White Label Liquid, Inc. stands at 2.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -99.9%, showing how much profit it generates from its asset base. A current ratio of 0.03 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -97.5%, the inverse of the P/E and a quick read on earnings relative to price.

WLAB Financials

WLAB Latest News

No recent news available for WLAB.

WLAB Analyst Consensus

WLAB MoonshotScore

WLAB Basic Materials Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources